UNH vs CVS
Based on Invest's signal, CVS HEALTH CORPORATION (CVS) currently has the stronger Buy/Hold/Sell rating of the two — a buy versus buy for UNH.
| Metric | UNH | CVS |
|---|---|---|
| Price | $420.74 | $107.74 |
| Day change | -0.7% | +0.8% |
| Market cap | $382.1B | $137.5B |
| P/E ratio | 31.8 | 78.1 |
| 1-year return | +43.8% | +74.2% |
| Invest signal | Buy | Buy |
Higher market cap, higher 1-year return, lower P/E, and a stronger signal are highlighted. Data is for learning, not financial advice.
Can't decide? Trade both — risk-free.
Start with €1,000,000 in virtual cash and practice buying UNH and CVS at live prices.
UNH vs CVS: FAQ
Is UNH or CVS the better stock to buy?
Based on Invest's signal, CVS HEALTH CORPORATION (CVS) currently has the stronger Buy/Hold/Sell rating of the two — a buy versus buy for UNH. Remember that Invest's signal is a data-driven snapshot for learning, not financial advice — the best way to understand the difference is to add both to a watchlist and practice trading them with virtual cash.
Which is bigger, UNH or CVS?
UNITEDHEALTH GROUP INCORPORATED (Delaware) is the larger company by market capitalisation ($382.1B vs $137.5B).
Can I practice trading UNH and CVS for free?
Yes. Invest is a free stock market simulator — you start with €1,000,000 in virtual cash and can buy and sell both UNH and CVS at live market prices, with no real money and no risk. It runs in your browser and as a free iOS app.